Target intelligence / Profile preview

Heme detoxification pathway in Plasmodium falciparum

Molecular classification
Other (pathway), Enzyme-mediated pathway (involving falcipain 2 protease, heme detoxification protein (HDP), and possibly lipid catalysis)
01

Overview

The **heme detoxification pathway in Plasmodium falciparum** is a critical metabolic route the malaria parasite uses to neutralize toxic free heme released during hemoglobin digestion inside infected red blood cells. Free heme, released as hemoglobin is broken down in the digestive vacuole, is highly cytotoxic due to its redox activity. To survive, the parasite converts this free heme into an insoluble crystalline form called hemozoin, a process facilitated primarily by enzymes such as falcipain 2 protease and the heme detoxification protein (HDP), and potentially lipid catalysis. Disruption of this pathway, particularly the inhibition of hemozoin formation, is the mode of action of several frontline antimalarials, including chloroquine, quinine, and artemisinin. These drugs prevent the detoxification of heme by interfering with its crystallization, leading to the accumulation of toxic heme and death of the parasite. The pathway is considered the "weakest link" in the parasite's lifecycle, making it a prime drug target in malaria treatment. Because the process and resulting hemozoin are unique to Plasmodium species, this pathway is highly selective as a therapeutic target, but the emergence of resistant parasite strains poses a growing challenge.

Other names
Heme detoxification processHemozoin formation pathwayPlasmodium heme detoxification
02

Mechanism of action

Inhibition of hemozoin (malarial pigment) crystallization Complexing with free heme to prevent detoxification Interfering with hemoglobin digestion enzymes

03

Biological functions

Detoxification of free hemeProtection from oxidative toxicityHemoglobin catabolism
04

Disease associations

Infection (specifically malaria caused by Plasmodium falciparum)
05

Safety considerations

Potential for off-target toxicity if drugs affect host heme or hemoglobin metabolismDevelopment of resistance, especially to chloroquine and artemisinin derivatives
06

Interacting drugs

Chloroquine

4 more in the full profile.

07

Biomarkers

Hemozoin levels (as a measure of pathway activity and efficacy of inhibition)Accumulation of free heme (indicator of pathway inhibition)

Beyond the preview

Go deeper on Heme detoxification pathway in Plasmodium falciparum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heme detoxification pathway in Plasmodium falciparum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call